semiconductor sequencing Roswell Biotechnologies Launches Molecular Electronics Chip, Pulls Focus to Binding Assays Premium The firm has developed a new way to look at biological binding dynamics, not only between DNA and polymerase but also for oligos, antibodies, and protein inhibitors. Roswell Biotechnologies, IMEC Partner on Biosensor Chips The firms have already completed proof-of-concept studies for their semiconductor biosensor chips and Roswell plans to have the initial chips by 2021. Genetron Health Gets China NMPA Approval for Clinical NGS System, Files for IPO The Genetron Health S5 NGS system is based on the Thermo Fisher Scientific Ion GeneStudio S5 and will be accompanied by Genetron-developed assays. GenapSys Targeting Smaller Labs With New Low-Cost Sequencer Premium Researchers at the Jackson Laboratory have tested an early version of the GenapSys sequencer and found it to have a very low mismatch error rate. GenapSys Raises $90M in Series C Round, Launches Sequencer in US The Redwood, California-based company plans to use the funding to drive the commercial launch of its semiconductor chip-based sequencing-by-synthesis instrument. Jan 10, 2018 Roswell Biotechnologies Harnesses Molecular Electronics for Chip-Based DNA Sequencing Premium Jan 9, 2018 Illumina Launches Semiconductor Sequencer, Partners With Thermo Fisher, Releases Prelim Earnings Sep 30, 2016 BARDA Awards $51.9M to DNAe to Develop Rapid Diagnostics Feb 26, 2016 Thermo Fisher Working on Direct Library Prep From Samples, 600 Base Reads for Ion Technology Premium Feb 12, 2016 At AGBT, Illumina Provides Additional Details on Project Firefly Jan 11, 2016 Illumina Unveils Mini Targeted Sequencer, Semiconductor Sequencing Project at JP Morgan Conference Jan 12, 2015 Nabsys, Ariana Pharmaceuticals Collaborate to ID Structural Variants Linked to Cancer Sep 24, 2013 Chinese Dx Firm iGenomics to Purchase 32 Ion Proton Sequencers Jun 17, 2013 Oxford Nanopore Disputes Comments by Illumina CEO Apr 23, 2013 Life Tech Participating in Scottish Stratified Medicine Initiative Apr 18, 2013 Life Tech, Ridom Partner on Bacterial Typing Software for Ion Torrent PGM Apr 16, 2013 Thermo Fisher Bullish on Ion Torrent Future as It Agrees to Buy Life Tech for $13.6B Premium Mar 13, 2013 Nabsys Raises $20M in Private Financing Round Jan 30, 2013 Life Tech Assembles Network of Centers to Evaluate PGM Protocol for Speedier Flu Tracking Premium Dec 10, 2012 Project Sequencing 100 Canadians to Launch This Week Oct 25, 2012 Life Tech to Supply Covaris Fragmenting System with Ion Torrent Sequencers Oct 18, 2012 Applied Markets Watch: GeneOnyx, DNA Electronics Launch Skincare Test Premium Sep 4, 2012 Oppenheimer Bullish on Life Tech's Ion Proton Instrument as Anticipated Launch Nears Aug 1, 2012 NY Genome Center Launches Innovation Center Jul 23, 2012 Life Technologies to Compete in Archon Genomics X Prize Load More Breaking News Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis Evvy Closes $14M Series A for Vaginal Microbiome Testing, Launches Add-on STI Screen Consanguinity Contributes to Common Disease Risk, Study Suggests Ginkgo Bioworks, Pfizer Ink RNA Drug Discovery Deal Worth up to $331M The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.